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In the previous issue of Critical Care, Gu and
colleagues reported the results of a systematic review
and meta-analysis of randomized trials comparing
high-frequency oscillatory ventilation (HFOV) with
conventional ventilation in adults with acute respiratory
distress syndrome (ARDS). In contrast to findings of prior
meta-analyses, their main finding was that, despite
reducing risks of oxygenation failure, HFOV does not
improve survival in adults with ARDS.increase in airway pressure with each inspiration. In thisIn the previous issue of Critical Care, Gu and colleagues
summarize the results of randomized controlled trials
comparing high-frequency oscillatory ventilation (HFOV)
to conventional ventilation in adults with acute respiratory
distress syndrome (ARDS) in a meta-analysis [1]. In this
report they incorporate results of new trials that were not
available when the previous systematic review on the topic
was published, which has led to a significant shift in con-
clusions [2].
HFOV emerged from physiological observations in the
late 1970s and entered routine clinical practice in neo-
natal and pediatric ICUs in the 1980s [3]. In adult ICUs,
HFOV uptake came at least a decade later, coincident
both with technological advances that allowed oscillation
of adult-sized patients and with increasing recognition
of the clinical impact of ventilator-induced lung injury
(VILI).
In contrast to conventional ventilation modes in which
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months following its publication. After this tim
License (http://creativecommons.org/licenses/
medium, provided the original work is proper
creativecommons.org/publicdomain/zero/1.0/generate tidal volumes, HFOV maintains a relatively
constant mean airway pressure and produces small oscil-
lations around this pressure to facilitate ventilation.
These small pressure swings and resultant small tidal
volumes are at the heart of the lung-protective potential
of HFOV [4]. Because tidal volumes are so small (often
less than anatomic dead space), the mean airway pressure
in HFOV - which physiologically functions like positive
end-expiratory pressure (PEEP) on conventional ventila-
tion - can often be set much higher than usual PEEP set-
tings because one does not have to leave room for a large
way, HFOV theoretically should be able to minimize VILI
by limiting cyclic overstretching (volutrauma) while main-
taining an adequate end-expiratory lung volume without
opening and closing injury (atelectrauma) [5].
On this theoretical background, and with the support
of animal studies showing enhanced lung protection
with HFOV, clinical trials comparing HFOV with con-
ventional ventilation in adults with ARDS have been
conducted. This is the dataset that Gu and colleagues set
out to summarize in their report. Using systematic
search methods, they found six randomized trials includ-
ing a total of 1,608 patients, although (it should be
noted) 84% of these patients were enrolled in two trials
published in 2013. The authors found no evidence sup-
porting the use of HFOV in reducing 30-day (relative
risk (RR) 1.05, 95% CI 0.83 to 1.36) or ICU (RR 1.22,
95% CI 0.93 to 1.64) mortality, and CIs were relatively
wide in both cases. It is important to note that the authors
found significant heterogeneity among the trials - perhaps
not surprising given that they were conducted over the
course of 15 years, with the evolution of ventilation
practices observed over that time [6]. In this sense, it
is difficult to interpret the promising results of the
earlier trials since they used now-outdated control strat-
egies with larger tidal volumes than would be prescribed
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tween the two recent trials - Oscillation for Acute Respi-
ratory Distress Syndrome Treated Early (OSCILLATE) [7]
and Oscillation in Acute Respiratory Distress Syndrome
(OSCAR) [8] - which were designed, conducted, and
published contemporaneously. OSCAR was designed as
a pragmatic trial examining the introduction of HFOV
to previously inexperienced ICUs and comparing this
with usual care. In contrast, OSCILLATE was designed
as a more explanatory trial, using centers with signifi-
cant oscillation experience and employing strict ventila-
tor protocols in both groups in an attempt to compare
optimal open-lung HFOV with optimal open-lung con-
ventional ventilation. OSCAR found identical outcomes
between groups, although the usual-care control group re-
ceived tidal volumes (mean day-1 tidal volume = 8.3 ±
2.9 mL/kg ideal body weight) that in some cases may have
caused volutrauma. Meanwhile, OSCILLATE was stopped
early for harm in the HFOV group, which may have been
easier to detect given the comparison with strict tidal
volume control and high levels of PEEP. Taken together
(as shown by Gu and colleagues), these trials strongly sug-
gest that there is no survival benefit to using HFOV as a
primary mode for lung protection in most adults with
moderate to severe ARDS. In this sense, this meta-analysis
is important as it systematically incorporates these data
into an updated estimate of treatment effect where previ-
ous reviews had suggested benefit of HFOV.
As the authors point out, none of the included trials
specifically studied a common indication for HFOV in
clinical practice: the patient failing conventional ventila-
tion. In that sense, we cannot comment directly on this
use of HFOV, although some may draw support for this
indication from the improvements in oxygenation as doc-
umented here. While I believe that certain patients with
severe ARDS may benefit from HFOV, the evidence com-
piled by Gu and colleagues suggests that these patients are
uncommon and may be difficult to identify. Given the
data supporting the use of other treatments in this sub-
group, such as higher PEEP [9], neuromuscular blockade
[10], and prone positioning [11], I believe that clinicians
should reach for the oscillator in rescue settings only after
having at least considered these other therapies.
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